|
|
|
Insider
Information: |
Mario Ernest |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
1,089,697 |
|
Indirect Shares
|
264,473 |
|
|
Direct
Value |
$8,309,557 |
|
|
Indirect Value
|
$120,004 |
|
|
Total
Shares |
1,354,170 |
|
|
Total
Value |
$8,429,560 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-41.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
Director |
2024-01-08 |
124,566 |
2024-01-08 |
20,752 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
372 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 13 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KIN |
Kindred Biosciences, Inc. |
Director |
|
2013-12-12 |
4 |
B |
$7.00 |
$175,000 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2015-02-09 |
4 |
B |
$5.85 |
$175,500 |
D/D |
30,000 |
196,472 |
2.39 |
- |
|
CELG |
Celgene Corp |
|
|
2019-02-12 |
4 |
B |
$89.99 |
$179,980 |
I/I |
2,000 |
2,000 |
0.01 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2016-06-24 |
4 |
B |
$3.70 |
$184,845 |
D/D |
50,000 |
381,440 |
2.39 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2020-03-24 |
4 |
B |
$2.27 |
$187,118 |
D/D |
82,431 |
327,239 |
2.39 |
% |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2015-07-17 |
4 |
B |
$7.50 |
$187,500 |
D/D |
25,000 |
225,472 |
2.39 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2015-06-25 |
4 |
OE |
$3.48 |
$191,397 |
D/D |
54,999 |
480,875 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2007-08-21 |
4 |
S |
$12.20 |
$203,740 |
I/I |
(16,700) |
0 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-02-03 |
4 |
OE |
$27.69 |
$212,272 |
D/D |
7,666 |
137,024 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-02-06 |
4 |
S |
$12.80 |
$218,935 |
D/D |
(17,104) |
347,855 |
0 |
- |
|
VVUS |
Vivus Inc |
Director |
|
2013-05-29 |
4 |
B |
$14.68 |
$220,206 |
D/D |
15,000 |
81,125 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2014-09-05 |
4 |
B |
$23.19 |
$231,872 |
D/D |
10,000 |
87,254 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2013-05-06 |
4 |
B |
$7.76 |
$232,800 |
D/D |
30,000 |
509,304 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2013-11-08 |
4 |
S |
$11.73 |
$239,857 |
I/I |
(20,445) |
0 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-03-05 |
4 |
A |
$85.97 |
$250,001 |
I/I |
2,908 |
4,908 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-03-05 |
4 |
D |
$85.97 |
$250,001 |
D/D |
(2,908) |
55,005 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2013-08-14 |
4 |
OE |
$54.35 |
$251,369 |
D/D |
4,625 |
85,671 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
Director |
|
2004-05-05 |
4 |
B |
$13.00 |
$260,000 |
D/D |
20,000 |
70,431 |
2.39 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2008-07-23 |
4 |
OE |
$12.81 |
$280,280 |
D/D |
20,000 |
228,027 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2014-11-05 |
4 |
B |
$29.00 |
$290,000 |
D/D |
10,000 |
106,053 |
2.39 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-08-01 |
4 |
B |
$58.10 |
$290,498 |
D/D |
5,000 |
42,370 |
2.39 |
- |
|
VVUS |
Vivus Inc |
Director |
|
2012-08-09 |
4 |
B |
$21.83 |
$327,399 |
D/D |
15,000 |
35,000 |
2.39 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2007-05-08 |
4 |
S |
$34.50 |
$331,413 |
I/I |
(9,605) |
335,947 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2014-04-07 |
4 |
OE |
$55.38 |
$332,280 |
D/D |
6,000 |
106,671 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2011-02-07 |
4 |
B |
$6.94 |
$346,990 |
D/D |
50,000 |
131,004 |
2.39 |
- |
|
372 Records found
|
|
Page 13 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|